Revolution Of Intel High Performance Processors In Personalized Medicine And Cancer Research

For the first time in history, Physicians are delivering truly personalized medicines to predict and treat disease. This is the direct result of advancing life science technology and high performance computing. Intel is proud to be a key player in the efforts to drive this biomedical revolution. Cancer has been an unreal target, DNA from a patients tumor is sequenced, a process that generates huge data files. Sophisticated genomics analytics software must make sense of that data and identify the relevant genotypes. A variety of analytics algorithms are then applied to help guide physicians in choosing just the right therapy and best prognosis based on the patients specific disease.

INTEL is working with industry specialist to accelerate these discoveries. Intel has taken end to end approach to understand industry challenges and need for complete analytics solutions. From locating advanced compute technologies close to the source of the data, to addressing the need for high performance packet processing and improvements in IO Network and storage, to seamlessly and securely working with complex workloads across both local clusters and cloud based analytics.

Supercomputer level performances deliver by Intel multicore Xeon processors and many core Intel Xeon Phi Coprocessors, when combined with Intel enterprise addition for luster, Intel solid-state drives, advanced networking, Intel true scale fabric and big data solutions like Intel distribution for Apache hadoop, you get the balanced, compute, storage and network performance you need to perform more simulations faster and get more accurate answers to your questions.